Investigating if E4orf1 can stop Alzheimer's disease from getting worse in older mice
Does E4orf1 prevent further deterioration in Alzheimer's disease pathology in older mice
This study is looking at a protein called E4orf1 to see if it can help stop Alzheimer's disease from getting worse in older mice, and it hopes to find new ways to treat the disease by understanding how Alzheimer's and Type 2 Diabetes are connected.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Texas Tech University NIH-funded |
| Lab location | 1 site (Lubbock, United States) |
| Project ID | NIH-10491189 on NIH RePORTER |
What this research studies
This research explores the potential of E4orf1, a protein, to prevent the worsening of Alzheimer's disease in older mice. By examining the relationship between Alzheimer's and Type 2 Diabetes, the study aims to uncover shared mechanisms that could lead to effective treatment strategies. The approach involves analyzing how E4orf1 interacts with molecular pathways involved in Alzheimer's progression. If successful, this research could pave the way for new therapies that might slow down or halt the disease's advancement.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults experiencing early signs of Alzheimer's disease or those at risk due to related conditions like Type 2 Diabetes.
Not a fit: Patients with advanced Alzheimer's disease or those without any cognitive decline may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that slow the progression of Alzheimer's disease.
How similar studies have performed: Previous research has shown promise in using anti-diabetic medications to improve cognitive function, indicating potential for success in this area.
Where this research is happening
Lubbock, United States
- Texas Tech University — Lubbock, United States (Active)
Researchers
- Principal investigator: Hegde, Vijay Karkal — Texas Tech University
- Study coordinator: Hegde, Vijay Karkal
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.